SCOPUS 정보 검색 플랫폼

British Journal of Clinical Pharmacology

Volumn 61, Issue 3, 2006, Pages 361-362

Author's reply: Hydroxylation of lansoprazole in poor metabolizers of CYP2C19 [2]

(4) Yasui Furukori, Norio a Uno, Tsukasa a Kaneko, Sunao a Tateishi, Tomonori a

a HIROSAKI UNIVERSITY (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYLANSOPRAZOLE; CLARITHROMYCIN; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; CYTOCHROME P450 INHIBITOR; DRUG METABOLITE; HYDROXYLANSOPRAZOLE; HYDROXYLANSOPRAZOLE SULPHONE; HYDROXYOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HYDROXYLATION; DRUG METABOLISM; HUMAN; LETTER; LIVER MICROSOME; PREDICTION; PRIORITY JOURNAL; SULFOXIDATION;

EID: 33644914469 PISSN: 03065251 EISSN: 13652125 Source Type: Journal
DOI: 10.1111/j.1365-2125.2005.02552.x Document Type: Letter

Times cited : (1)

References (6)

1
- 0032843591
- Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans
- Furuta T Ohashi K Kobayashi K Iida I Yoshida H Shirai N Takashima M Kosuge K Hanai H Chiba K Ishizaki T Kaneko E Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans Clin Pharmacol Ther 1999 66 265 74
- (1999) Clin Pharmacol Ther , vol.66 , pp. 265-74
- Furuta, T.¹ Ohashi, K.² Kobayashi, K.³ Iida, I.⁴ Yoshida, H.⁵ Shirai, N.⁶ Takashima, M.⁷ Kosuge, K.⁸ Hanai, H.⁹ Chiba, K.¹⁰ Ishizaki, T.¹¹ Kaneko, E.¹²

2
- 15244345927
- Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes
- Saito M Yasui-Furukori N Uno T Takahata T Sugawara K Munakata A Tateishi T Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes Br J Clin Pharmacol 2005 59 302 9
- (2005) Br J Clin Pharmacol , vol.59 , pp. 302-9
- Saito, M.¹ Yasui-Furukori, N.² Uno, T.³ Takahata, T.⁴ Sugawara, K.⁵ Munakata, A.⁶ Tateishi, T.⁷

3
- 0028923801
- Oxidative metabolism of lansoprazole by human liver cytochromes P450
- Pichard L Curi-Pedrosa R Bonfils C Jacqz-Aigrain E Domergue J Joyeux H Cosme J Guengerich FP Maurel P Oxidative metabolism of lansoprazole by human liver cytochromes P450 Mol Pharmacol 1995 47 410 8
- (1995) Mol Pharmacol , vol.47 , pp. 410-8
- Pichard, L.¹ Curi-Pedrosa, R.² Bonfils, C.³ Jacqz-Aigrain, E.⁴ Domergue, J.⁵ Joyeux, H.⁶ Cosme, J.⁷ Guengerich, F.P.⁸ Maurel, P.⁹

4
- 0035660655
- Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes
- Katsuki H Hamada A Nakamura C Arimori K Nakano M Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes Eur J Clin Pharmacol 2001 57 709 15
- (2001) Eur J Clin Pharmacol , vol.57 , pp. 709-15
- Katsuki, H.¹ Hamada, A.² Nakamura, C.³ Arimori, K.⁴ Nakano, M.⁵

5
- 10744225323
- Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes
- Kim KA Kim MJ Park JY Shon JH Yoon YR Lee SS Liu KH Chun JH Hyun MH Shin JG Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes Drug Metab Dispos 2003 31 1227 34
- (2003) Drug Metab Dispos , vol.31 , pp. 1227-34
- Kim, K.A.¹ Kim, M.J.² Park, J.Y.³ Shon, J.H.⁴ Yoon, Y.R.⁵ Lee, S.S.⁶ Liu, K.H.⁷ Chun, J.H.⁸ Hyun, M.H.⁹ Shin, J.G.¹⁰

6
- 0028276695
- Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism
- Andersson T Miners JO Veronese ME Birkett DJ Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism Br J Clin Pharmacol 1994 37 597 604
- (1994) Br J Clin Pharmacol , vol.37 , pp. 597-604
- Andersson, T.¹ Miners, J.O.² Veronese, M.E.³ Birkett, D.J.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.